« Retourner aux résultats de recherche

• Citer

Patient preferences for treatments to delay bone metastases.

par Hauber, Brett AB;Arellano, Jorge;Qian, Yi;González, Juan Marcos;Posner, Joshua JD;Mohamed, Ateesha AF;Gatta, Francesca;Tombal, Bertrand;Body, Jean-Jacques
Référence The Prostate, 74, 15, page (1488-1497)
Publication Publié, 2014-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Most patients with advanced prostate cancer (PCa) develop bone metastases (BM) and present with bone complications like fracture. Bone-targeted agents that prevent metastasis-induced bone complications can cause adverse events. Understanding how patients view treatment options may optimize care. This study aimed to quantify how PCa patients value a hypothetical treatment that delays BM but can cause osteonecrosis of the jaw (ONJ). The study also assessed the value patients place on avoiding metastasis-induced bone complications versus increased survival.